176 related articles for article (PubMed ID: 27885796)
1. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Aigelsreiter A; Neumann J; Pichler M; Halasz J; Zatloukal K; Berghold A; Douschan P; Rainer F; Stauber R; Haybaeck J; Denk H; Lackner C
Liver Int; 2017 Apr; 37(4):600-610. PubMed ID: 27885796
[TBL] [Abstract][Full Text] [Related]
2. Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions.
Mahajan V; Klingstedt T; Simon R; Nilsson KP; Thueringer A; Kashofer K; Haybaeck J; Denk H; Abuja PM; Zatloukal K
Gastroenterology; 2011 Sep; 141(3):1080-1090.e1-7. PubMed ID: 21699779
[TBL] [Abstract][Full Text] [Related]
3. In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62.
Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Hepatology; 2007 Sep; 46(3):851-60. PubMed ID: 17685470
[TBL] [Abstract][Full Text] [Related]
4. Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?
Denk H; Stumptner C; Fuchsbichler A; Müller T; Farr G; Müller W; Terracciano L; Zatloukal K
J Pathol; 2006 Apr; 208(5):653-61. PubMed ID: 16477590
[TBL] [Abstract][Full Text] [Related]
5. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
Hanada S; Strnad P; Brunt EM; Omary MB
Hepatology; 2008 Sep; 48(3):943-52. PubMed ID: 18697208
[TBL] [Abstract][Full Text] [Related]
6. From Mallory to Mallory-Denk bodies: what, how and why?
Zatloukal K; French SW; Stumptner C; Strnad P; Harada M; Toivola DM; Cadrin M; Omary MB
Exp Cell Res; 2007 Jun; 313(10):2033-49. PubMed ID: 17531973
[TBL] [Abstract][Full Text] [Related]
7. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.
Stumptner C; Heid H; Fuchsbichler A; Hauser H; Mischinger HJ; Zatloukal K; Denk H
Am J Pathol; 1999 Jun; 154(6):1701-10. PubMed ID: 10362795
[TBL] [Abstract][Full Text] [Related]
8. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation.
Harada M; Hanada S; Toivola DM; Ghori N; Omary MB
Hepatology; 2008 Jun; 47(6):2026-35. PubMed ID: 18454506
[TBL] [Abstract][Full Text] [Related]
9. Autophagy is involved in the elimination of intracellular inclusions, Mallory-Denk bodies, in hepatocytes.
Harada M
Med Mol Morphol; 2010 Mar; 43(1):13-8. PubMed ID: 20340001
[TBL] [Abstract][Full Text] [Related]
10. p62/Sequestosome-1 Is Indispensable for Maturation and Stabilization of Mallory-Denk Bodies.
Lahiri P; Schmidt V; Smole C; Kufferath I; Denk H; Strnad P; Rülicke T; Fröhlich LF; Zatloukal K
PLoS One; 2016; 11(8):e0161083. PubMed ID: 27526095
[TBL] [Abstract][Full Text] [Related]
11. Identification of p62, a phosphotyrosine independent ligand of p56lck kinase, as a major component of intracytoplasmic hyaline bodies in hepatocellular carcinoma.
Stumptner C; Heid H; Zatloukal K; Fuchsbichler A; Hauser H; Denk H
Verh Dtsch Ges Pathol; 1999; 83():254-9. PubMed ID: 10714219
[TBL] [Abstract][Full Text] [Related]
12. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
Ku NO; Strnad P; Zhong BH; Tao GZ; Omary MB
Hepatology; 2007 Nov; 46(5):1639-49. PubMed ID: 17969036
[TBL] [Abstract][Full Text] [Related]
13. "Toxic memory" via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction.
Strnad P; Tao GZ; So P; Lau K; Schilling J; Wei Y; Liao J; Omary MB
Hepatology; 2008 Sep; 48(3):931-42. PubMed ID: 18697205
[TBL] [Abstract][Full Text] [Related]
14. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
Tan CT; Soh NJH; Chang HC; Yu VC
FEBS J; 2023 Feb; 290(4):892-912. PubMed ID: 34882306
[TBL] [Abstract][Full Text] [Related]
15. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Denk H; Stumptner C; Abuja PM; Zatloukal K
Expert Opin Ther Targets; 2019 May; 23(5):393-406. PubMed ID: 30987486
[TBL] [Abstract][Full Text] [Related]
16. Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies.
Strnad P; Zatloukal K; Stumptner C; Kulaksiz H; Denk H
Biochim Biophys Acta; 2008 Dec; 1782(12):764-74. PubMed ID: 18805482
[TBL] [Abstract][Full Text] [Related]
17. Mallory-Denk bodies and hepatocellular senescence: a causal relationship?
Denk H; Abuja PM; Zatloukal K
Virchows Arch; 2024 Apr; 484(4):637-644. PubMed ID: 38289501
[TBL] [Abstract][Full Text] [Related]
18. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.
Hanada S; Snider NT; Brunt EM; Hollenberg PF; Omary MB
Gastroenterology; 2010 Apr; 138(4):1607-17. PubMed ID: 20064513
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria.
Singla A; Moons DS; Snider NT; Wagenmaker ER; Jayasundera VB; Omary MB
Hepatology; 2012 Jul; 56(1):322-31. PubMed ID: 22334478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
